Skip to main content
. Author manuscript; available in PMC: 2014 Jun 24.
Published in final edited form as: Biol Blood Marrow Transplant. 2009 Sep 1;15(11):1431–1438. doi: 10.1016/j.bbmt.2009.07.008

Table 1.

Conditioning
1995–1999 (N=63) 2000–2004 (N=67)

N (%) N (%)
Reduced intensity 28 (44%) 30 (45%)
Fludarabine / Melphalan 10 (16%) 14 (21%)
Busulfan / Fludarabine 1 (1%) 16 (24%)
Miscellaneous 17 (27%) 0 (0%)
Ablative 35 (56%) 37 (55%)
TBI Containing 15 (24%) 2 (3%)
Busulfan / Cyclophosphamide 20 (32%) 12 (18%)
Busulfan / Fludarabine 0 (0%) 23 (34%)
Stem Cell Source N (%) N (%)

Matched Related 42 (67%) 30 (45%)
Matched Unrelated 13 (21%) 31 (46%)
Mis-matched Related 7 (11%) 3 (5%)
Mis-matched Unrelated 0 2 (3%)
Cord Blood 1 (1%) 1 (1%)

Baseline HSCT characteristics. The conditioning regimens and stem cell sources for the 130 allogeneic transplants performed after 1st salvage (S1) are shown above for the time periods 1995–1999 and 2000–2004. Over this time frame more matched unrelated donor transplants were performed. The conditioning regimens used also changed with fewer TBI containing regimens being employed and the majority of transplants being performed with busulfan / fludarabine based conditioning.